The global market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors was valued at US$ 9451 million in the year 2024 and is projected to reach a revised size of US$ 11030 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes.

North American market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors include Eli Lilly, Glaxo Smith Kline, Boehringer, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Novo Nordisk, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.

The Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Report

Report Metric	Details
Report Name	Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
Accounted market size in year	US$ 9451 million
Forecasted market size in 2031	US$ 11030 million
CAGR	2.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Sitagliptin Saxagliptin Vildagliptin Linagliptin
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly, Glaxo Smith Kline, Boehringer, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Novo Nordisk
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market growing?

Ans: The Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market size in 2031?

Ans: The Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market size in 2031 will be US$ 11030 million.

Who are the main players in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market report?

Ans: The main players in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market are Eli Lilly, Glaxo Smith Kline, Boehringer, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Novo Nordisk

What are the Application segmentation covered in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market report?

Ans: The Applications covered in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market report?

Ans: The Types covered in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market report are Sitagliptin, Saxagliptin, Vildagliptin, Linagliptin

1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview

1.1 Product Definition

1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type

1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Type (2024 VS 2031)

1.2.2 Sitagliptin

1.2.3 Saxagliptin

1.2.4 Vildagliptin

1.2.5 Linagliptin

1.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application

1.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Estimates and Forecasts

1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2020-2031

1.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2020-2031

1.4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competition by Manufacturers

2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2020-2025)

2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Product Type & Application

2.7 Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Date of Enter into This Industry

2.8 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation and Trends

2.8.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players Market Share by Revenue

2.8.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Scenario by Region

3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2020-2031

3.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2020-2025

3.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2026-2031

3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2020-2031

3.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2020-2025

3.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2026-2031

3.4 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country

3.4.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2031)

3.4.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country

3.5.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2031)

3.5.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Region

3.6.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2020-2031)

3.6.3 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country

3.7.1 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2031)

3.7.3 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2031)

3.8.3 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2031)

4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2020-2025)

4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2026-2031)

4.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2031)

4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2020-2031)

4.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2020-2025)

4.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2026-2031)

4.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2020-2031)

4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2020-2031)

5 Segment by Application

5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2031)

5.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2020-2025)

5.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2026-2031)

5.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2031)

5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2020-2031)

5.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2020-2025)

5.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2026-2031)

5.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2020-2031)

5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eli Lilly

6.1.1 Eli Lilly Company Information

6.1.2 Eli Lilly Description and Business Overview

6.1.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.1.5 Eli Lilly Recent Developments/Updates

6.2 Glaxo Smith Kline

6.2.1 Glaxo Smith Kline Company Information

6.2.2 Glaxo Smith Kline Description and Business Overview

6.2.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.2.5 Glaxo Smith Kline Recent Developments/Updates

6.3 Boehringer

6.3.1 Boehringer Company Information

6.3.2 Boehringer Description and Business Overview

6.3.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.3.5 Boehringer Recent Developments/Updates

6.4 Bristol-Myers Squibb

6.4.1 Bristol-Myers Squibb Company Information

6.4.2 Bristol-Myers Squibb Description and Business Overview

6.4.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.4.5 Bristol-Myers Squibb Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Company Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Company Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.6.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 Sanofi

6.7.1 Sanofi Company Information

6.7.2 Sanofi Description and Business Overview

6.7.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 Novo Nordisk

6.8.1 Novo Nordisk Company Information

6.8.2 Novo Nordisk Description and Business Overview

6.8.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio

6.8.5 Novo Nordisk Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Chain Analysis

7.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Mode & Process Analysis

7.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Marketing

7.4.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Channels

7.4.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors

7.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customer Analysis

8 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Dynamics

8.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends

8.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Drivers

8.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Challenges

8.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation by Manufacturers in 2024

Table 4. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2020-2025) & (Units)

Table 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2020-2025)

Table 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2026-2031) & (Units)

Table 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2026-2031)

Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2020-2025)

Table 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2026-2031)

Table 25. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)

Table 27. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (Units)

Table 28. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)

Table 32. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (Units)

Table 33. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)

Table 42. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (Units)

Table 43. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Type (2020-2025)

Table 51. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Type (2026-2031)

Table 52. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)

Table 53. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2026-2031)

Table 54. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2020-2025)

Table 57. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2026-2031)

Table 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2020-2025)

Table 59. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2026-2031)

Table 60. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Application (2020-2025)

Table 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Application (2026-2031)

Table 62. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2025)

Table 63. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2026-2031)

Table 64. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2020-2025)

Table 67. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2026-2031)

Table 68. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2020-2025)

Table 69. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2026-2031)

Table 70. Eli Lilly Company Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 74. Eli Lilly Recent Developments/Updates

Table 75. Glaxo Smith Kline Company Information

Table 76. Glaxo Smith Kline Description and Business Overview

Table 77. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 79. Glaxo Smith Kline Recent Developments/Updates

Table 80. Boehringer Company Information

Table 81. Boehringer Description and Business Overview

Table 82. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 84. Boehringer Recent Developments/Updates

Table 85. Bristol-Myers Squibb Company Information

Table 86. Bristol-Myers Squibb Description and Business Overview

Table 87. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 89. Bristol-Myers Squibb Recent Developments/Updates

Table 90. Pfizer Company Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 94. Pfizer Recent Developments/Updates

Table 95. AstraZeneca Company Information

Table 96. AstraZeneca Description and Business Overview

Table 97. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 99. AstraZeneca Recent Developments/Updates

Table 100. Sanofi Company Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 104. Sanofi Recent Developments/Updates

Table 105. Novo Nordisk Company Information

Table 106. Novo Nordisk Description and Business Overview

Table 107. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product

Table 109. Novo Nordisk Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List

Table 113. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List

Table 114. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Trends

Table 115. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Drivers

Table 116. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Challenges

Table 117. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Type: 2024 & 2031

Figure 4. Sitagliptin Product Picture

Figure 5. Saxagliptin Product Picture

Figure 6. Vildagliptin Product Picture

Figure 7. Linagliptin Product Picture

Figure 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Others

Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size (2020-2031) & (US$ Million)

Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (2020-2031) & (Units)

Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (USD/Unit) & (2020-2031)

Figure 17. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Report Years Considered

Figure 18. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2024

Figure 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players: Market Share by Revenue in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in 2024

Figure 21. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)

Figure 24. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)

Figure 28. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)

Figure 29. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2020-2031)

Figure 36. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)

Figure 47. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2020-2031)

Figure 57. Global Revenue Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2020-2031)

Figure 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2020-2031)

Figure 60. Global Revenue Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2020-2031)

Figure 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2020-2031)

Figure 62. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Dipeptidyl Peptidase IV DPP IV Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DPP 4 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025

Global Tagliptin Market Research Report 2024

DPP 4 Inhibitor Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Linagliptin Market Research Report 2024

Global Alogliptin Benzoate Reagent Market Research Report 2024

Global Sitagliptin Intermediates Market Research Report 2024

Global Diabetes Peptide Drugs Market Research Report 2025

Global GLP 1 Receptor Antagonist Market Research Report 2024

GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sitagliptin Phosphate API Market Research Report 2025

Global GLP 1 Drug Peptide API Market Research Report 2024

Global Alogliptin Market Research Report 2024

Global Oral Antidiabetic Drugs Market Insights Forecast to 2030

Global DPP 4 Inhibitor Innovative Drugs Market Research Report 2025

Global Oral Antidiabetic Agents Market Insights Forecast to 2030

Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024

Global Oral GLP 1 Agonist Market Research Report 2024

Global Peptide Drugs for Diabetes Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions